O'Regan RM - Search Results

1

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.

Graham TR, Zhau HE, Odero-Marah VA, Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW, O'Regan RM. Graham TR, et al. Cancer Res. 2008 Apr 1;68(7):2479-88. doi: 10.1158/0008-5472.CAN-07-2559. Cancer Res. 2008. PMID: 18381457

2

Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.

O'Regan RM, Osipo C, Ariazi E, Lee ES, Meeke K, Morris C, Bertucci A, Sarker MA, Grigg R, Jordan VC. O'Regan RM, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2255-63. doi: 10.1158/1078-0432.CCR-05-2584. Clin Cancer Res. 2006. PMID: 16609042

3

Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry.

Xing Y, Chaudry Q, Shen C, Kong KY, Zhau HE, Chung LW, Petros JA, O'Regan RM, Yezhelyev MV, Simons JW, Wang MD, Nie S. Xing Y, et al. Nat Protoc. 2007;2(5):1152-65. doi: 10.1038/nprot.2007.107. Nat Protoc. 2007. PMID: 17546006

4

Adjuvant hormonal therapy for early-stage breast cancer.

Zelnak AB, O'Regan R. Zelnak AB, et al. Cancer Treat Res. 2008;141:63-78. doi: 10.1007/978-0-387-73161-2_5. Cancer Treat Res. 2008. PMID: 18274083 Review. No abstract available.

5

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor.

Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM, Sharma D. Saxena NK, et al. Cancer Res. 2008 Dec 1;68(23):9712-22. doi: 10.1158/0008-5472.CAN-08-1952. Cancer Res. 2008. PMID: 19047149 Free PMC article.

6

Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer.

Rizzo M, Lund MJ, Mosunjac M, Bumpers H, Holmes L, O'Regan R, Brawley OW, Gabram S. Rizzo M, et al. Cancer. 2009 Jul 1;115(13):3009-15. doi: 10.1002/cncr.24334. Cancer. 2009. PMID: 19466698 Free article.

7

In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells.

Ozbay T, Durden DL, Liu T, O'Regan RM, Nahta R. Ozbay T, et al. Cancer Chemother Pharmacol. 2010 Mar;65(4):697-706. doi: 10.1007/s00280-009-1075-9. Epub 2009 Jul 28. Cancer Chemother Pharmacol. 2010. PMID: 19636556 Free PMC article.

8

Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.

Graham TR, Yacoub R, Taliaferro-Smith L, Osunkoya AO, Odero-Marah VA, Liu T, Kimbro KS, Sharma D, O'Regan RM. Graham TR, et al. Breast Cancer Res Treat. 2010 Aug;123(1):139-47. doi: 10.1007/s10549-009-0623-7. Epub 2009 Nov 18. Breast Cancer Res Treat. 2010. PMID: 19921427 Free PMC article.

9

Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells.

Liu T, Yacoub R, Taliaferro-Smith LD, Sun SY, Graham TR, Dolan R, Lobo C, Tighiouart M, Yang L, Adams A, O'Regan RM. Liu T, et al. Mol Cancer Ther. 2011 Aug;10(8):1460-9. doi: 10.1158/1535-7163.MCT-10-0925. Epub 2011 Jun 20. Mol Cancer Ther. 2011. PMID: 21690228 Free PMC article.

10

Treatment adherence and outcome in women with inflammatory breast cancer: does race matter?

Andic F, Godette K, O'Regan R, Zelnak A, Liu T, Rizzo M, Gabram S, Torres M. Andic F, et al. Cancer. 2011 Dec 15;117(24):5485-92. doi: 10.1002/cncr.26187. Epub 2011 Jun 20. Cancer. 2011. PMID: 21692059 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters